
According to a University of Pittsburgh Cancer Institute (UPCI) study that will be presented on Dec. 11, 2009, patients who are being treated for a metastatic breast cancer for the second time may get better results if Avastin is added to their treatment.
Avastin inhibits the formation of new blood vessels that would supply tumors with oxygen and nutrients needed to grow, said the director of the Breast Cancer Center at Magee Womens Hospital of UPMC.
The study showed that Avastin added to standard chemotherapy improved survival.
Nearly 200,000 individuals will be diagnosed with breast cancer in 2010, and over 40,000 will die from breast cancer.
Post a Comment to "Avastin Improves Survival of Breast Cancer Patients, says UPMC Study"
To reply to this message, enter your reply in the box labeled "Message", hit "Post Message."
6 Things You Must Know About Colon Cancer

9 Biggest Mistakes Made by Your Gynecologist

9 Rules to Follow When You See A Doctor - Your Safety Is At Stake!

Berger & Lagnese, LLC
310 Grant Street
Suite 720
Pittsburgh, PA 15219
Phone: (412) 471-4300
Fax: (412) 471-3116
Toll Free: (800) 350-6161
Get Directions